BioSpace News Archive

Pharm Country

Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta

Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP in 18, 27, 36, and 54 mg strengths.

February 5, 2018

·

2 min read

Biotech Bay

Accuray Retires February 2018 Convertible Notes

Accuray announced today it has retired all February 2018 convertible notes, including $13M aggregate principal amount of its 3.50% convertible senior notes and $27M aggregate principal amount of its 3.50% Series A convertible senior notes both due February 1, 2018.

February 5, 2018

·

3 min read

Business

SCIEX Announces Co-Marketing Agreement With IROA Technologies LLC to Improve Metabolite Identification & Quantitation in Complex Samples for Untargeted Metabolomics

Under this Agreement, IROA Technologies and SCIEX will promote a unique measurement system called the IROA Workflow with SWATH Acquisition based on next-generation metabolomics and TripleTOF Systems.

February 5, 2018

·

4 min read

Genetown

Alnylam to Webcast Presentations at Upcoming February BIO CEO and Global Healthcare Investor Conferences

A live audio webcast of each presentation will be available on the Investors section of the Company’s website, www.alnylam.com.

February 5, 2018

·

2 min read

Drug Development

Spectrum Pharmaceuticals Announces ROLONTIS (eflapegrastim) Met the Primary Endpoint in the Phase III ADVANCE Study

Spectrum announced today that the first Phase 3 study of ROLONTIS, ADVANCE, has met its primary endpoint of non-inferiority in Duration of Severe Neutropenia in comparison to pegfilgrastim.

February 5, 2018

·

5 min read

Genetown

H3 Biomedicine to Present at 2018 BIO CEO & Investor Conference

H3 Biomedicine announced that company management will present an overview of the company at the 2018 BIO CEO & Investor Conference on Monday, February 12, 2018, at 9:45 a.m. EST at the New York Marriott Marquis in New York.

February 5, 2018

·

1 min read

Business

Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results

Bristol-Myers Squibb posted fourth quarter 2017 revenues of $5.4 billion, an increase of 4% compared to the same period a year ago.

February 5, 2018

·

22 min read

Pharm Country

IDEXX Advances Power of SediVue Dx with Latest Software Update

IDEXX Labs today announced the release of its Neural Network 3.0 software update for the IDEXX SediVue Dx Urine Sediment Analyzer.

February 5, 2018

·

3 min read

Drug Development

Palatin Technologies Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist

Top line data is currently expected in the third quarter of 2018.

February 5, 2018

·

4 min read

Bionik Launches New Commercial Generation InMotion Arm Robotic System to Improve Rehabilitation for Stroke Survivors

The improved new generation InMotion Arm will provide the same innovative active-assisted robotic therapy, but with a new industrial design that is modern, smaller and sleeker.

February 5, 2018

·

7 min read